The Influence of Isorel on Advanced Colorectal Cancer
This 2003 randomized, controlled clinical study investigated the impact of Isorel, a mistletoe extract (Viscum album L.), as an adjunct therapy in patients with advanced colorectal cancer (Dukes C and D stages). Participants were allocated into three groups: surgery alone, surgery plus standard 5-fluorouracil (5-FU) chemotherapy, and surgery plus chemotherapy
June 26, 2025
No Comments